CTKB
Cytek Biosciences, Inc.
7.65
USD
This page is just a preview of the data found in TrendSpider’s full version
Cytek Biosciences, Inc. stock is up 53% since 30 days ago. The next earnings date is Feb 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 December’s closed higher than November. 0% of analysts rate it a buy.
Cytek Biosciences, Inc. provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that deliver cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. The company also provides reagents and kits, including cFluor reagents.
